ABSTRACT
Background Complex anatomy surrounding the oropharynx makes proton therapy (PT) especially intensity-modulated PT (IMPT) a good option due to its ability to reduce the volume of irradiated healthy tissues. Dosimetric improvement may not translate to clinically relevant benefit. As outcome data are emerging, we aimed to systematically review current evidence of the quality of life (QOL) and patient-reported outcomes (PRO) following PT of oropharyngeal carcinoma (OC).
Materials and Methods We searched PubMed and Scopus electronic databases to identify eligible reports on QOL and PRO following PT of OC according to PRISMA guidelines. Reports were extracted for information on demographics, main results and clinical and dose factors correlates.
Results Six reports were selected from which four compared between PT and photon-based therapy. All endpoints where significant differences were found favour PT. The change following treatment improves but never to the baseline level.
Conclusion Available evidence suggests that PT causes less QOL deterioration and PRO compared to photon therapy. Whether or not it is cost-effective should be a subject of further investigation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval: This article does not contain any studies with human participants performed by any of the authors.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Compliance with Ethical Standards Funding: National University of Malaysia, GP-2019-K017963 (ukm.edu.my) to NY.
Conflict of Interest: Authors declare no conflict of interest.
Ethical approval: This article does not contain any studies with human participants performed by any of the authors.
Data available on request from the authors The data that support the findings of this study are available from the corresponding author upon reasonable request.
Data Availability
All data is available within this manuscript
Abbreviations
- PT
- Proton therapy
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
